Introducing the concept of the 3Rs into tissue engineering research

Altex

Volumn 23, Issue 1, 2006, Pages 17-23

  Eder, Claudia ^a   Falkner, Erwin ^a,b   Nehrer, Stefan ^b   Losert, Udo M ^b   Schöffl, Harald ^c  

^a Biomed Society for the Promotion of Biomedical and Medical Technological Research in Upper Austria   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Centre for Alternative and Complementary Methods to Animal Testing   (Austria)

Author keywords

Antibiotic free cell culture; HET CAM; Serum free cell culture; The 3Rs; Tissue engineering

Indexed keywords

ANIMAL; ANIMAL TESTING ALTERNATIVE; ARTICLE; CHICK EMBRYO; CHORIOALLANTOIS; CULTURE MEDIUM; CULTURE TECHNIQUE; MATERIALS TESTING; METHODOLOGY; PHYSIOLOGY; SHEEP; TISSUE CULTURE TECHNIQUE; TISSUE ENGINEERING;

ANIMAL TESTING ALTERNATIVES; ANIMALS; CELL CULTURE TECHNIQUES; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CULTURE MEDIA; MATERIALS TESTING; SHEEP; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING;

EID: 33747838561     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Austrian Federal Law 1989 regulating experimental Procedures on living animals, 27 September 1989. http://www.bmbwk.gv.at/forschung/recht/tierversuche/ tvg.xml?style=print (last accessed 5.11.2005).
2. Borges, J., Tegtmeier, F. T., Padron, N. T. et al. (2003). Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Engineering 9(3), 441-450.
3. Brown, L. D. and Schneider, M. F. (2002). Delayed dedifferentiation and retention of properties in dissociated adult skeletal muscle fibres in vitro. In Vitro Cell Dev. Biol. Anim. 38(7), 411-422.
4. Carticel package insert http://www.carticel.com/pdfs/carticel-product- label.pdf (last accessed 29.12.2005).
5. Chaipinyo, K., Oakes, B. W. and van Damme, M. P. (2002). Effects of growth factors on cell proliferation and matrix synthesis of low-density, primary bovine chondrocytes cultured in collagen I gels. J. Orthop. Res. 20(5), 1070-1078.
6. Chua, K. H., Aminuddin, B. S., Fuzina, N. H. and Ruszymah, B. H. I. (2005). Insulin-Transferrin-Selenium prevent human chondrocyte dedifferentiation and promote the formation of high quality tissue engineered human hyaline cartilage. European Cells and Materials 9, 58-67.
7. Eder, C., Falkner, E., Mickel, M. et al. (2005). A Modified HET-CAM Approach for Biocompatibility Testing Of Medical Devices. Animal Welfare 14(4), 297-302. (Pubitemid 41645482)
8. European commission, Health & Consumer Protection Directorate (2001). Opinion on the state of the art concerning tissue engineering, europa.eu.int/comm/food/fs/sc/scmp/out37-en.pdf (last accessed 5.11.2005).
9. Falkner, E., Schöffl, H., Appl, H. et al. (2003). Replacement of Sera for Cell Culture Purposes: A Survey, ISBN 3-900131-00-7, Linz, Austria.
10. Falkner, E., Eder, C. and Kapeller, B. et al. (2004). The mandatory CAM testing of cells and scaffolds for tissue engineering: Benefits for the 3Rs of cooperation with the vaccine industry. ATLA 32, 573-580.
11. Fraud, S. J. (1999). The development benefits and disadvantages of serum free media. Dev. Bio. Stand. 99, 157-166
12. Gauchia, R., Rodriguez-Serna, M., Silvestre, J. F. et al. (1996). Allergic contact dermatitis from streptomycin in a cattle breed. Contact Dermatitis 35(6), 374-375.
13. Gstraunthaler, G. (2003). Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX 20(4), 275-281.
14. Jennings, A. (1999). Detecting viruses in sera: methods used and their merits. Dev. Biol. Stand. 99, 51-59.
15. Jochems, C. E. A., van der Valk, J. B., Stafleu, F. R. and Baumans, V. (2002). The use of fetal bovine serum: ethical or scientific problem? ATLA 30, 219-227.
16. Jux C., Wohlsein, P., Bruegmann, M. et al. (2003). A new biological matrix for septal occlusion. Journal of Interventional Cardiology 6(2), 149-152.
17. Kalweit, S., Gerner, I. and Spielmann, H. (1987). Validation project of alternatives for the Draize eye test. Molecular Toxicology 1, 597-603.
18. Kappeler, A., Lutz-Wallace, C., Sapp, T. and Sidhu, M. (1996). Detection of bovine polyomavirus contamination in fetal bovine sera and modified live viral vaccines using polymerase chain reaction. Biologicals 24(2), 131-135. (Pubitemid 26335417)
19. Kuhlman, I. (1993). Problems of the prophylactic use of antibiotics in cell culture. ALTEX 10(2), 27-49.
20. Louhimies, S. (2002). Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes. ATLA 30, Suppl. 2, 217-219.
21. Mackensen, A., Drager, R., Schlesier, M. et al. (2000). Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol. Immunother. 49(3), 152-156.
22. Merten, O. W. (1999). Safety issues of animal products used in serum free media. Dev. Bio. Stand. 99, 167-180.
23. Morgan, T. J., Xu, X., Rowan, A. D. and Cawston, T. E. (2005). Evaluation of chondrocyte micromass culture for the study of cartilage degradation. Arthritis Research & Therapy 7 (Suppl 1), 58.
24. Ndiritu, C. G. and Enos, L. R. (1977). Adverse reactions to drugs in a veterinary hospital. J. Am. Vet. Med. Assoc. 171(4), 335-339.
25. Rhangan, S. R. and Gallagher, R. E. (1979). Tumors and viruses in non-human primates. Adv. Virus Res. 24, 1-123.
26. Romeis, B. (1989). Mikroskopische Technik (Title translation: Microscopic technology). Munich, Germany: Urban & Schwarzenberg.
27. Russel, W. M. S. and Burch, R. L. (1959, reprinted 1992). The principles of humane experimental technique. Wheathampstead, UK: Universities Federation for Animal Welfare. http://www.forschung3r.ch/de/publications/bu7.html (last accessed 5.11.2005).
28. Shah, G. (1999). Why do we still use serum in the production of biopharmaceuticals? Dev. Biol. Stand. 99,17-22.
29. Spees, J. L., Gregory, C. A., Singh, H. et al. (2004). Internalised antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol. Ther. 9(5), 747-756.
30. Spielmann, H. (1995). HET-CAM test. Methods in Molecular Biology 43, 199-204.
31. Tschuong L., Soenen, S. L., Blaese, R. M. et al. (2002). Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum. Gene Ther. 13(13), 1605-1610.
32. Tumia, N. S. and Johnstone, J. (2004). Promoting the Proliferative and Synthetic Activity of Knee Meniscal Fibrochondrocytes Using Basic Fibroblast Growth Factor In Vitro. The American Journal of Sports Medicine 32, 915-920. (Pubitemid 38669385)
33. van der Noordaa, J., Sol, C. J. and Schuurman, R. (1999). Bovine polyoma virus, a frequent contaminant of calf sera. Dev. Biol. Stand. 99, 45-47.
34. van der Valk J., Mellor, D., Brands, R. et al. (2004). The humane collection of fetal bovine serum and possibilities for serum free cell and tissue culture. Toxicol. in vitro 18(1), 1-12.
35. van Tienhoven, E. A. E, Geertsma, R. E., Wassenaar, C. and Jong, W. H. (2001). Pre-clinical safety assessment of Tissue Engineered Medical Products (TEMPs) - An investigation on assays and guidelines for biocompatibility testing http://www.rivm.nl/bibliotheek/rapporten/640080002.html (last accessed 29.12.2005).
36. Yokoyama, A. (2004). Microglia, a potential source of neurons, astrocytes, and oligodendrocytes. Glia 45(1), 96-104.